Advertisement

Clinical Drug Investigation

, Volume 13, Issue 5, pp 277–281 | Cite as

Patient Acceptability of Two Different Brands of Nicotine Chewing Gum

  • M. Rasmussen
  • J. T. Jørgensen
  • J. Rømsing
Outcomes Research

Summary

The aim of this controlled, randomised, crossover study was to evaluate the patient acceptability of 2 different nicotine chewing gum brands on the Danish market, Nicotinell® (Ciba-Geigy) and Nicorette® (Pharmacia Upjohn). 20 healthy smokers tested one brand in one week and the next week were crossed over to the alternative product. From scores on a 10cm visual analogue scale (VAS) combined with descriptive words it was shown that taste, texture and stickiness were significantly (p < 0.0001, p < 0.0003, and p < 0.005, respectively) better accepted over time for Nicotinell® than for Nicorette®. At the end of the 2-week study period, the participants were asked to give their preference and 90% of the subjects preferred Nicotinell® to Nicorette®.

Keywords

Nicotine Visual Analogue Scale Score Drug Invest Nicotine Addiction Patient Acceptability 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jarvik ME. Biological factors underlying the smoking habit. In: Jarvik ME, Cullen JW, Gritz ER, et al., editors. Research on smoking behaviour. Washington DC: National Institute on Drug Abuse, 1977: 122–48. Department of Health, Education and Welfare publication (ADM) 78-581Google Scholar
  2. 2.
    Schacter S. Pharmacological and psychological determinants of smoking. Ann Intern Med 1978; 88(4): 104–14Google Scholar
  3. 3.
    Benowitz NL. Drug therapy: pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319(20): 1318–30PubMedCrossRefGoogle Scholar
  4. 4.
    Lam W, Sze PC, Sacks HS, et al. Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet 1987; II(1): 27–9CrossRefGoogle Scholar
  5. 5.
    Alsagoff F, Lee HP. Nicotine-replacement products in smoking cessation: a review. Singapore Med J 1993; 34: 505–10PubMedGoogle Scholar
  6. 6.
    Jensen EJ, Schmidt E, Pedersen B, et al. Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation. Thorax 1990; 45: 831–4PubMedCrossRefGoogle Scholar
  7. 7.
    Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7–20PubMedCrossRefGoogle Scholar
  8. 8.
    Data on file. Clinical Expert Report. 1993Google Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  • M. Rasmussen
    • 1
  • J. T. Jørgensen
    • 2
  • J. Rømsing
    • 1
  1. 1.Department of PharmaceuticsThe Royal Danish School of PharmacyCopenhagenDenmark
  2. 2.Ciba-Geigy LtdCopenhagenDenmark

Personalised recommendations